{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:24:19Z","timestamp":1790821459381,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,2,9]],"date-time":"2015-02-09T00:00:00Z","timestamp":1423440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,2,9]],"date-time":"2015-02-09T00:00:00Z","timestamp":1423440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1038\/nm.3776","type":"journal-article","created":{"date-parts":[[2015,2,9]],"date-time":"2015-02-09T12:29:02Z","timestamp":1423484942000},"page":"276-280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease"],"prefix":"10.1038","volume":"21","author":[{"given":"Mathias","family":"Riebold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kozany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Freiburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sattler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Buchfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Hausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter K","family":"Stalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Paez-Pereda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,9]]},"reference":[{"key":"BFnm3776_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/edrv-5-1-1","volume":"5","author":"ME Keller-Wood","year":"1984","unstructured":"Keller-Wood, M.E. & Dallman, M.F. Corticosteroid inhibition of ACTH secretion. Endocr. Rev. 5, 1\u201324 (1984).","journal-title":"Endocr. Rev."},{"key":"BFnm3776_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1210\/edrv.20.2.0358","volume":"20","author":"PLM Dahia","year":"1999","unstructured":"Dahia, P.L.M. & Grossman, A.B. The molecular pathogenesis of corticotroph tumors. Endocr. Rev. 20, 136\u2013155 (1999).","journal-title":"Endocr. Rev."},{"key":"BFnm3776_CR3","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","volume":"367","author":"J Newell\u2013Price","year":"2006","unstructured":"Newell\u2013Price, J., Bertagna, X., Grossman, A.B. & Nieman, L.K. Cushing's syndrome. Lancet 367, 1605\u20131617 (2006).","journal-title":"Lancet"},{"key":"BFnm3776_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nrendo.2011.12","volume":"7","author":"NA Tritos","year":"2011","unstructured":"Tritos, N.A., Biller, B.M. & Swearingen, B. Management of Cushing disease. Nat. Rev. Endocrinol. 7, 279\u2013289 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"key":"BFnm3776_CR5","first-page":"296","volume":"108","author":"M Karl","year":"1996","unstructured":"Karl, M. et al. Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proc. Assoc. Am. Physicians 108, 296\u2013307 (1996).","journal-title":"Proc. Assoc. Am. Physicians"},{"key":"BFnm3776_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0303-7207(02)00280-0","volume":"197","author":"SWJ Lamberts","year":"2002","unstructured":"Lamberts, S.W.J. Glucocorticoid receptors and Cushing's disease. Mol. Cell. Endocrinol. 197, 69\u201372 (2002).","journal-title":"Mol. Cell. Endocrinol."},{"key":"BFnm3776_CR7","first-page":"306","volume":"18","author":"WB Pratt","year":"1997","unstructured":"Pratt, W.B. & Toft, D.O. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 18, 306\u2013360 (1997).","journal-title":"Endocr. Rev."},{"key":"BFnm3776_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/348166a0","volume":"348","author":"D Picard","year":"1990","unstructured":"Picard, D. et al. Reduced levels of Hsp90 compromise steroid-receptor action in vivo. Nature 348, 166\u2013168 (1990).","journal-title":"Nature"},{"key":"BFnm3776_CR9","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1073\/pnas.96.4.1439","volume":"96","author":"KI Kang","year":"1999","unstructured":"Kang, K.I. et al. The molecular chaperone Hsp90 can negatively regulate the activity of a glucocorticosteroid-dependent promoter. Proc. Natl. Acad. Sci. USA 96, 1439\u20131444 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3776_CR10","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1126\/science.1073051","volume":"296","author":"BC Freeman","year":"2002","unstructured":"Freeman, B.C. & Yamamoto, K.R. Disassembly of transcriptional regulatory complexes by molecular chaperones. Science 296, 2232\u20132235 (2002).","journal-title":"Science"},{"key":"BFnm3776_CR11","doi-asserted-by":"publisher","first-page":"37181","DOI":"10.1074\/jbc.M003701200","volume":"275","author":"MG Marcu","year":"2000","unstructured":"Marcu, M.G., Chadli, A., Bouhouche, I., Catelli, M. & Neckers, L.M. The heat shock protein 90 antagonist novobiocin interacts with a previously unrecognized ATP-binding domain in the carboxyl terminus of the chaperone. J. Biol. Chem. 275, 37181\u201337186 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnm3776_CR12","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1016\/j.bmcl.2010.12.088","volume":"21","author":"H Zhao","year":"2011","unstructured":"Zhao, H., Brandt, G.E., Galam, L., Matts, R.L. & Blagg, B.S.J. Identification and initial SAR of silybin: An Hsp90 inhibitor. Bioorg. Med. Chem. Lett. 21, 2659\u20132664 (2011).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFnm3776_CR13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2887","volume":"10","author":"J Trepel","year":"2010","unstructured":"Trepel, J., Mollapour, M., Giaccone, G. & Neckers, L. Targeting the dynamic Hsp90 complex in cancer. Nat. Rev. Cancer 10, 537\u2013549 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm3776_CR14","doi-asserted-by":"publisher","first-page":"7185","DOI":"10.1038\/sj.onc.1210534","volume":"26","author":"P Garc\u00eda-Morales","year":"2007","unstructured":"Garc\u00eda-Morales, P. et al. Inhibition of Hsp90 function by ansamycins causes downregulation of cdc2 and cdc25c and G2\/M arrest in glioblastoma cell lines. Oncogene 26, 7185\u20137193 (2007).","journal-title":"Oncogene"},{"key":"BFnm3776_CR15","first-page":"705","volume":"10","author":"L Whitesell","year":"1996","unstructured":"Whitesell, L. & Cook, P. Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells. Mol. Endocrinol. 10, 705\u2013712 (1996).","journal-title":"Mol. Endocrinol."},{"key":"BFnm3776_CR16","doi-asserted-by":"publisher","first-page":"18694","DOI":"10.1074\/jbc.272.30.18694","volume":"272","author":"B Segnitz","year":"1997","unstructured":"Segnitz, B. & Gehring, U. The function of steroid hormone receptors is inhibited by the Hsp90-specific compound geldanamycin. J. Biol. Chem. 272, 18694\u201318701 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnm3776_CR17","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1021\/cb200052x","volume":"6","author":"RL Matts","year":"2011","unstructured":"Matts, R.L. et al. Elucidation of the Hsp90 C-terminal inhibitor binding site. ACS Chem. Biol. 6, 800\u2013807 (2011).","journal-title":"ACS Chem. Biol."},{"key":"BFnm3776_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0092-8674(02)01250-3","volume":"112","author":"JC Young","year":"2003","unstructured":"Young, J.C., Hoogenraad, N.J. & Hartl, F.U. Molecular chaperones Hsp90 and Hsp70 deliver preproteins to the mitochondrial import receptor Tom70. Cell 112, 41\u201350 (2003).","journal-title":"Cell"},{"key":"BFnm3776_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/jnci\/92.3.242","volume":"92","author":"MG Marcu","year":"2000","unstructured":"Marcu, M.G., Schulte, T.W. & Neckers, L. Novobiocin and related coumarins and depletion of heat shock protein 90\u2013dependent signaling proteins. J. Natl. Cancer Inst. 92, 242\u2013248 (2000).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFnm3776_CR20","doi-asserted-by":"publisher","first-page":"8217","DOI":"10.1021\/bi0497998","volume":"43","author":"BG Yun","year":"2004","unstructured":"Yun, B.G., Huang, W., Leach, N., Hartson, S.D. & Matts, R.L. Novobiocin induces a distinct conformation of Hsp90 and alters Hsp90\u2013cochaperone\u2013client interactions. Biochemistry 43, 8217\u20138229 (2004).","journal-title":"Biochemistry"},{"key":"BFnm3776_CR21","doi-asserted-by":"publisher","first-page":"21213","DOI":"10.1074\/jbc.272.34.21213","volume":"272","author":"KD Dittmar","year":"1997","unstructured":"Dittmar, K.D., Demady, D.R., Stancato, L.F., Krishna, P. & Pratt, W.B. Folding of the glucocorticoid receptor by the heat shock protein (Hsp) 90-based chaperone machinery: the role of p23 is to stabilize receptor\u2013Hsp90 heterocomplexes formed by Hsp90-p60-Hsp70. J. Biol. Chem. 272, 21213\u201321220 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnm3776_CR22","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.cell.2014.04.038","volume":"157","author":"E Kirschke","year":"2014","unstructured":"Kirschke, E., Goswami, D., Southworth, D., Griffin, P. & Agard, D. Glucocorticoid receptor function regulated by coordinated action of the Hsp90 and Hsp70 chaperone cycles. Cell 157, 1685\u20131697 (2014).","journal-title":"Cell"},{"key":"BFnm3776_CR23","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.molcel.2012.11.017","volume":"49","author":"O Genest","year":"2013","unstructured":"Genest, O. et al. Uncovering a region of heat shock protein 90 important for client binding in E. coli and chaperone function in yeast. Mol. Cell 49, 464\u2013473 (2013).","journal-title":"Mol. Cell"},{"key":"BFnm3776_CR24","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.molcel.2014.02.003","volume":"53","author":"OR Lorenz","year":"2014","unstructured":"Lorenz, O.R. et al. Modulation of the Hsp90 chaperone cycle by a stringent client protein. Mol. Cell 53, 941\u2013953 (2014).","journal-title":"Mol. Cell"},{"key":"BFnm3776_CR25","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1172\/JCI11098","volume":"108","author":"M P\u00e1ez-Pereda","year":"2001","unstructured":"P\u00e1ez-Pereda, M. et al. Retinoic acid prevents experimental Cushing syndrome. J. Clin. Invest. 108, 1123\u20131131 (2001).","journal-title":"J. Clin. Invest."},{"key":"BFnm3776_CR26","doi-asserted-by":"publisher","first-page":"36223","DOI":"10.1074\/jbc.M206748200","volume":"277","author":"S Kaul","year":"2002","unstructured":"Kaul, S. et al. Mutations at positions 547\u2013553 of rat glucocorticoid receptors reveal that Hsp90 binding requires the presence, but not defined composition, of a seven\u2013amino acid sequence at the amino terminus of the ligand binding domain. J. Biol. Chem. 277, 36223\u201336232 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnm3776_CR27","doi-asserted-by":"publisher","first-page":"5952","DOI":"10.1128\/MCB.17.10.5952","volume":"17","author":"A Philips","year":"1997","unstructured":"Philips, A. et al. Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Mol. Cell. Biol. 17, 5952\u20135959 (1997).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm3776_CR28","first-page":"3978","volume":"12","author":"B Liu","year":"1992","unstructured":"Liu, B., Hammer, G.D., Rubinstein, M., Mortrud, M. & Low, M.J. Identification of DNA elements cooperatively activating proopiomelanocortin gene expression in the pituitary glands of transgenic mice. Mol. Cell. Biol. 12, 3978\u20133990 (1992).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm3776_CR29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/BF00431389","volume":"396","author":"CK Leung","year":"1982","unstructured":"Leung, C.K., Paterson, J., Imai, Y. & Shiu, R. Transplantation of ACTH-secreting pituitary tumor cells in athymic nude mice. Virchows Arch. A Pathol. Anat. Histol. 396, 303\u2013312 (1982).","journal-title":"Virchows Arch. A Pathol. Anat. Histol."},{"key":"BFnm3776_CR30","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1101\/gad.1444606","volume":"20","author":"S Bilodeau","year":"2006","unstructured":"Bilodeau, S. et al. Role of Brg1 and HDAC2 in GR trans\u2013repression of the pituitary POMC gene and misexpression in Cushing disease. Genes Dev. 20, 2871\u20132886 (2006).","journal-title":"Genes Dev."},{"key":"BFnm3776_CR31","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0960-0760(03)00218-8","volume":"85","author":"T Kino","year":"2003","unstructured":"Kino, T., De Martino, M.U., Charmandari, E., Mirani, M. & Chrousos, G.P. Tissue glucocorticoid resistance\/hypersensitivity syndromes. J. Steroid Biochem. Mol. Biol. 85, 457\u2013467 (2003).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"BFnm3776_CR32","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.2174\/092986708786242895","volume":"15","author":"A Donnelly","year":"2008","unstructured":"Donnelly, A. & Blagg, B.S.J. Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket. Curr. Med. Chem. 15, 2702\u20132717 (2008).","journal-title":"Curr. Med. Chem."},{"key":"BFnm3776_CR33","doi-asserted-by":"publisher","first-page":"18487","DOI":"10.1073\/pnas.0609163103","volume":"103","author":"L Fang","year":"2006","unstructured":"Fang, L., Ricketson, D., Getubig, L. & Darimont, B. Unliganded and hormone-bound glucocorticoid receptors interact with distinct hydrophobic sites in the Hsp90 C-terminal domain. Proc. Natl. Acad. Sci. USA 103, 18487\u201318492 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3776_CR34","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.molcel.2006.07.016","volume":"23","author":"CK Vaughan","year":"2006","unstructured":"Vaughan, C.K. et al. Structure of an Hsp90\u2013Cdc37\u2013Cdk4 Complex. Mol. Cell 23, 697\u2013707 (2006).","journal-title":"Mol. Cell"},{"key":"BFnm3776_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.tibs.2013.02.003","volume":"38","author":"A R\u00f6hl","year":"2013","unstructured":"R\u00f6hl, A., Rohrberg, J. & Buchner, J. The chaperone Hsp90: changing partners for demanding clients. Trends Biochem. Sci. 38, 253\u2013262 (2013).","journal-title":"Trends Biochem. Sci."},{"key":"BFnm3776_CR36","doi-asserted-by":"publisher","first-page":"33698","DOI":"10.1074\/jbc.M204164200","volume":"277","author":"KC Kanelakis","year":"2002","unstructured":"Kanelakis, K.C., Shewach, D.S. & Pratt, W.B. Nucleotide binding states of Hsp70 and Hsp90 during sequential steps in the process of glucocorticoid receptor\u2013Hsp90 heterocomplex assembly. J. Biol. Chem. 277, 33698\u201333703 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnm3776_CR37","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1074\/jbc.M512406200","volume":"281","author":"RK Allan","year":"2006","unstructured":"Allan, R.K., Mok, D., Ward, B.K. & Ratajczak, T. Modulation of chaperone function and cochaperone interaction by novobiocin in the C-terminal domain of Hsp90: evidence that coumarin antibiotics disrupt Hsp90 dimerization. J. Biol. Chem. 281, 7161\u20137171 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnm3776_CR38","doi-asserted-by":"publisher","first-page":"7066","DOI":"10.1074\/jbc.M105568200","volume":"277","author":"C S\u00f6ti","year":"2002","unstructured":"S\u00f6ti, C., R\u00e1cz, A. & Csermely, P. A nucleotide-dependent molecular switch controls ATP binding at the C-terminal domain of Hsp90: N-terminal nucleotide binding unmasks a C-terminal binding pocket. J. Biol. Chem. 277, 7066\u20137075 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnm3776_CR39","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.canlet.2008.03.053","volume":"269","author":"K Ramasamy","year":"2008","unstructured":"Ramasamy, K. & Agarwal, R. Multitargeted therapy of cancer by silymarin. Cancer Lett. 269, 352\u2013362 (2008).","journal-title":"Cancer Lett."},{"key":"BFnm3776_CR40","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.2165\/00003495-200161140-00003","volume":"61","author":"R Saller","year":"2001","unstructured":"Saller, R., Meier, R. & Brignoli, R. The use of silymarin in the treatment of liver diseases. Drugs 61, 2035\u20132063 (2001).","journal-title":"Drugs"},{"key":"BFnm3776_CR41","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1021\/ct100334n","volume":"6","author":"G Morra","year":"2010","unstructured":"Morra, G. et al. Dynamics-based discovery of allosteric inhibitors: selection of new ligands for the C-terminal domain of Hsp90. J. Chem. Theory Comput. 6, 2978\u20132989 (2010).","journal-title":"J. Chem. Theory Comput."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nm.3776.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm.3776","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm.3776.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T08:26:16Z","timestamp":1650356776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.3776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["BFnm3776"],"URL":"https:\/\/doi.org\/10.1038\/nm.3776","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725346876.793507100","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.725346876.793530683","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,9]]},"assertion":[{"value":"12 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}